Press "esc" to clear
Go to Advanced Search

Showing results

110 of 3634
Embargo will expire:
19-Nov-2018 9:15 AM EST
Released to reporters:
16-Nov-2018 11:05 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 19-Nov-2018 9:15 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
19-Nov-2018 1:00 AM EST
Released to reporters:
16-Nov-2018 9:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 19-Nov-2018 1:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

  • Embargo expired:
    16-Nov-2018 12:05 AM EST

Article ID: 704076

Preventable Hospital Readmissions Cut by More Than 25 Percent Under Innovative Contract Between University of Pennsylvania Health System and Independence Blue Cross

Perelman School of Medicine at the University of Pennsylvania

After the first year of an innovative, five-year contract between the University of Pennsylvania Health System (UPHS) and Independence Blue Cross (Independence), the health system is reporting a more than 25 percent cut in hospital readmissions – the largest readmission reduction in both organizations’ history. As part of the first collaboration of its kind in the United States between a health system and a health insurer, the two organizations have launched a new slate of innovations to reduce the number of patients who return to the hospital within a month of going home. The contract provided that Independence wouldn’t pay for the resulting hospitalization in those cases.

Released:
15-Nov-2018 12:05 PM EST
screenshotnew.png

Article ID: 704092

The Association of American Cancer Institutes Debuts New Website

Association of American Cancer Institutes (AACI)

The Association of American Cancer Institutes is excited to announce the launch of its redesigned website (aaci-cancer.org). The revamped internet presence will enhance communication between AACI and its 98 cancer center members and within the cancer research and advocacy community.

Released:
15-Nov-2018 1:05 PM EST
chuckie-michael-320x180.jpg

Article ID: 704075

Ashkenazi Jewish Founder Mutation Identified in Leigh Syndrome

Children's Hospital of Philadelphia

Decades after two brothers died in childhood from a mitochondrial disease, scientists pinpointed the genetic cause as a founder mutation in an Ashkenazi Jewish ancestor. The discoverers say the causative gene should be included in prenatal genetic carrier screening tests.

Released:
15-Nov-2018 12:05 PM EST
  • Embargo expired:
    15-Nov-2018 11:00 AM EST

Article ID: 703902

Anti-Malaria Drugs Have Shown Promise in Treating Cancer, and Now Researchers Know Why

Perelman School of Medicine at the University of Pennsylvania

Anti-malaria drugs known as chloroquines have been repurposed to treat cancer for decades, but until now no one knew exactly what the chloroquines were targeting when they attack a tumor. Now, researchers from the Abramson Cancer Center of the University of Pennsylvania say they have identified that target – an enzyme called PPT1.

Released:
13-Nov-2018 12:05 PM EST
2018_AIS_Tower.jpg

Article ID: 704064

Art in Science and Medicine: From Serendipity to Study Aid

Perelman School of Medicine at the University of Pennsylvania

Winners of Penn's Art in Science competition feature beautiful visual images produced using methods of scientific inquiry. And next month, a new medical student group will host its first-ever Penn Med art show to highlight the artistic talents of medical students, faculty, and staff.

Released:
15-Nov-2018 10:05 AM EST
Daphne_Lichtensztajn.jpg
  • Embargo expired:
    15-Nov-2018 9:00 AM EST

Article ID: 704043

Latino Men are Much Less Likely to Receive Optimal Treatment for High Risk Prostate Cancer than White Men, According to New Research in JNCCN

National Comprehensive Cancer Network® (NCCN®)

New research published in JNCCN-Journal of the National Comprehensive Cancer Network found Latino men were 21% less likely to receive definitive treatment compared to non-Latino white men, with significant differences for younger patients, the uninsured, and those treated at NCI-designated centers.

Released:
14-Nov-2018 4:45 PM EST
  • Embargo expired:
    15-Nov-2018 12:00 AM EST

Article ID: 703364

Best of Meeting Abstract: Treatment for Joint Pain Is Less Helpful for Pain but Effective for Anxiety and Sleep Disturbance

American Society of Regional Anesthesia and Pain Medicine (ASRA)

Patients with centralized pain (fibromyalgia-like phenotype) are less likely to respond to a type of facet joint pain treatment called radiofrequency ablation (RFA), according to the results of a study from researchers at the University of Michigan in Ann Arbor, MI.

Released:
12-Nov-2018 12:00 AM EST
  • Embargo expired:
    15-Nov-2018 12:00 AM EST

Article ID: 703363

Best of Meeting Abstract: Study Finds Genetic Risk Score Correlates with Headache Prevalence and Severity

American Society of Regional Anesthesia and Pain Medicine (ASRA)

A higher polygenic risk score—a genetic analysis computed from a combination of several of a person’s genes—is associated with more frequent and severe headaches. The findings support the idea that a propensity for headaches has a genetic basis.

Released:
12-Nov-2018 12:00 AM EST

Showing results

110 of 3634

Chat now!